Anxiolytic effects of valproate and diazepam in mice are differentially sensitive to picrotoxin antagonism

被引:31
作者
Dalvi, A [1 ]
Rodgers, RJ [1 ]
机构
[1] Univ Leeds, Sch Psychol, Ethopharmacol Lab, Leeds LS2 9JT, W Yorkshire, England
关键词
anxiety; plus-maze; GABA; diazepam; valproate; picrotoxin; mice;
D O I
10.1016/S0091-3057(00)00408-1
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Although it is widely believed that the anxiolytic effects of benzodiazepines are mediated through facilitation of GABA(A) receptor function, behavioural studies have to date provided rather weak support for this hypothesis. In particular, considerable inconsistency has been noted both for the effects of GABAergic manipulations in animal models of anxiety and the ability of GABAA receptor antagonists to block the anxiolytic effects of diazepam (DZ) and chlordiazepoxide. In view of the sensitivity of the murine plus-maze to the anxiety-modulating effects of GABAergic agents as well as classical benzodiazepines, the current study examined the extent to which the anxiolytic actions of valproic acid (VPA) and DZ in this test involve picrotoxin (PX)-sensitive receptor mechanisms. Subjects were male DBA/2 mice, test duration was 5 min, and ethological scoring methods were employed. Our results show that, while devoid of intrinsic behavioural effects under present test conditions. PX (0.25 - 0.5 mg/kg) selectively antagonised the anxiolytic-like (but not other) effects of VPA (400 mg;kg). In contrast, the same doses of PX failed to block any of the behavioural changes induced by DZ (1.5 mg/kg), including disinhibition of open arm exploration. These data suggest that the plus-maze anxiolytic effects of DZ in DBA/2 mice are not mediated through PX-sensitive GABA, receptors. Further studies will be required to assess the generality of present findings to other mouse strains, species and behavioural paradigms. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 92 条
[1]  
AGMO A, 1991, N-S ARCH PHARMACOL, V344, P314
[2]   Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze [J].
Anseloni, VZ ;
Brandao, ML .
BEHAVIOURAL PHARMACOLOGY, 1997, 8 (6-7) :533-540
[3]   PILOT-STUDY OF PK-11195, A SELECTIVE LIGAND FOR THE PERIPHERAL-TYPE BENZODIAZEPINE BINDING-SITES, IN INPATIENTS WITH ANXIOUS OR DEPRESSIVE SYMPTOMATOLOGY [J].
ANSSEAU, M ;
VONFRENCKELL, R ;
CERFONTAINE, JL ;
PAPART, P .
PHARMACOPSYCHIATRY, 1991, 24 (01) :8-12
[4]   VALPROIC ACID - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN INDICATIONS OTHER THAN EPILEPSY [J].
BALFOUR, JA ;
BRYSON, HM .
CNS DRUGS, 1994, 2 (02) :144-173
[5]  
BARROS HMT, 1992, BRAZ J MED BIOL RES, V25, P281
[6]   GABA RECEPTOR AGONISTS - PHARMACOLOGICAL SPECTRUM AND THERAPEUTIC ACTIONS [J].
BARTHOLINI, G .
MEDICINAL RESEARCH REVIEWS, 1985, 5 (01) :55-75
[7]   EFFECTS OF NALOXONE AND PICROTOXIN ON SEDATIVE AND ANTICONFLICT EFFECTS OF BENZODIAZEPINES [J].
BILLINGSLEY, ML ;
KUBENA, RK .
LIFE SCIENCES, 1978, 22 (10) :897-906
[8]  
BUCKLAND C, 1986, PSYCHOPHARMACOLOGY, V88, P285
[9]  
CANNIZZARO G, 1987, ARZNEIMITTEL-FORSCH, V37-1, P6
[10]  
COLE JC, 1993, BEHAV PHARMACOL, V4, P573